Wells Fargo’s Boston Scientific BSX Stock Holding History

Wells Fargo’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-285,000	Closed	-$17.9M	–	7314
2026 Q1	$17.9M	Buy	285,000 +56,700	+25%	+$4.54M	﹤0.01%	1588
2025 Q4	$21.8M	Buy	+228,300	New	+$22.4M	﹤0.01%	1445
2025 Q1	–	Sell	-20,000	Closed	-$1.79M	–	7050
2024 Q4	$1.79M	Buy	+20,000	New	+$1.76M	﹤0.01%	3276
2022 Q2	–	Sell	-11,900	Closed	-$527K	–	6825
2022 Q1	$527K	Buy	11,900 +11,700	+5,850%	+$507K	﹤0.01%	4369
2021 Q4	$8K	Buy	+200	New	+$8.4K	﹤0.01%	6610
2021 Q3	–	Sell	-12,000	Closed	-$513K	–	6983
2021 Q2	$513K	Buy	+12,000	New	+$505K	﹤0.01%	4603
2020 Q4	–	Sell	-38,000	Closed	-$1K	–	6498
2020 Q3	$1K	Sell	38,000 -637,000	-94%	-$24.5M	﹤0.01%	6182
2020 Q2	$291K	Buy	+675,000	New	+$24.3M	﹤0.01%	4679
2019 Q3	–	Sell	-90,800	Closed	-$80K	–	6379
2019 Q2	$80K	Buy	+90,800	New	+$3.49M	﹤0.01%	5393
2019 Q1	–	Sell	-229,800	Closed	-$111K	–	6057
2018 Q4	$111K	Buy	229,800 +183,800	+400%	+$6.67M	﹤0.01%	5232
2018 Q3	$25K	Buy	+46,000	New	+$1.61M	﹤0.01%	5772

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo's BSX Position: Q2 2026 in Review

Wells Fargo increased its Boston Scientific (BSX) stake by 2.7% in Q2 2026, buying an estimated $4.36M and bringing the position to 3,051,613 shares worth $130M. The position accounts for 0.02% of the portfolio, ranked #567.

Wells Fargo first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $493M in Q4 2019. 1,483 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Wells Fargo held 3,051,613 shares of Boston Scientific worth $130M as of Q2 2026.
Wells Fargo bought 80,291 Boston Scientific shares in Q2 2026, an estimated $4.36M.
Boston Scientific made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #567 holding.
Wells Fargo first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's Boston Scientific position peaked at $493M in Q4 2019.
1,483 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.